LB Pharmaceuticals Inc Common Stock LBRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.97M+67.0% | $16.74M+93.9% | $8.64M-48.8% | $16.88M— | —— | ||
| $18.11M+32.6% | $13.66M+1.7% | $13.44M-16.2% | $16.03M— | —— | ||
| $46.08M+51.6% | $30.4M+37.7% | $22.07M-32.9% | $32.91M— | —— | ||
| $7.14M+37.0% | $5.21M+58.8% | $3.28M-6.1% | $3.49M— | —— | ||
| -$38.95M-54.5% | -$25.2M-34.0% | -$18.8M+36.1% | -$29.43M— | —— | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K— | —— | ||
| -$38.95M-54.5% | -$25.2M-34.0% | -$18.8M+36.1% | -$29.43M+43.6% | -$52.19M+17.3% | ||
| —— | —— | —— | —— | —— | ||
| -$38.63M-55.2% | -$24.88M-34.2% | -$18.54M+36.6% | -$29.22M— | —— | ||
| -$38.95M-54.5% | -$25.2M-34.0% | -$18.8M+36.1% | -$29.43M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LB Pharmaceuticals Inc Common Stock profitable?
- LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's earnings per share?
- LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
- Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.